Respuesta :
a. Avoiding subQ and IM injections
b. Bleeding is the major complication of treatment
c. Minimizing invasive procedures
These are correct nursing implications for the administration of the thrombolytic drug alteplase (tPA). It's important to avoid subcutaneous (subQ) and intramuscular (IM) injections because of the increased risk of bleeding. Bleeding is indeed the major complication associated with thrombolytic therapy, and minimizing invasive procedures helps to reduce the risk of bleeding. Alteplase is typically administered intravenously (IV), and the dosing may involve an initial IV bolus followed by an infusion, not as a single IV bolus.
b. Bleeding is the major complication of treatment
c. Minimizing invasive procedures
These are correct nursing implications for the administration of the thrombolytic drug alteplase (tPA). It's important to avoid subcutaneous (subQ) and intramuscular (IM) injections because of the increased risk of bleeding. Bleeding is indeed the major complication associated with thrombolytic therapy, and minimizing invasive procedures helps to reduce the risk of bleeding. Alteplase is typically administered intravenously (IV), and the dosing may involve an initial IV bolus followed by an infusion, not as a single IV bolus.